Nevisense
JSON twin: https://www.healthaidb.com/software/nevisense.json
Company Name
SciBase
Product URL
https://scibase.com/us/
Company URL
https://scibase.com
Categories
Summary
Nevisense is a non-invasive diagnostic device developed by SciBase, utilizing advanced Electrical Impedance Spectroscopy (EIS) combined with artificial intelligence to enhance the early detection of skin cancers, particularly melanoma, at the point of care.
Description
Nevisense is a point-of-care diagnostic device that employs Electrical Impedance Spectroscopy (EIS) technology integrated with artificial intelligence to assess suspicious pigmented skin lesions. It provides clinicians with objective, actionable data to support early detection and management of skin cancers, including melanoma and non-melanoma types. The device is FDA-approved and CE-marked, ensuring its safety and efficacy in clinical settings. Nevisense has been utilized in over 300,000 patient tests globally, demonstrating its effectiveness in improving diagnostic accuracy and patient outcomes. The platform has evolved through several iterations, with Nevisense 3.0 offering a streamlined workflow and enhanced performance, and Nevisense V introducing an updated user interface and improved display resolution. Additionally, Nevisense has been adapted for research applications, such as assessing skin barrier function in atopic dermatitis studies. SciBase continues to advance Nevisense, aiming to expand its capabilities and applications in dermatology.
Api Available
unknown
Certifications
- FDA 510(k)
- CE/MDR
- TGA
- ISO 13485
- MDR
Company Founding
2000
Company Offices
Compliance
- HIPAA
- GDPR
- HITECH
- SOC 2
- ISO 27001
- MDR
- FDA 510(k)
- CE/MDR
- TGA
- ISO 13485
Customers
- Over 300,000 patients tested with Nevisense
Data Residency
EU-only, US/EU regions, BYO cloud region
Data Standards
- FHIR
- HL7 v2
- DICOM
- SNOMED
- ICD-10
Deployment Model
Features
- Non-invasive melanoma detection
- Skin barrier assessment
- Atopic dermatitis evaluation
- AI-driven diagnostic support
- Electrical Impedance Spectroscopy (EIS) technology
- Point-of-care testing
- Clinical workflow integration
- FDA-approved system
- CE marked in Europe
- TGA approval in Australia
- MDR certified in Europe
- Clinical studies supporting efficacy
- User-friendly interface
- Real-time results
- Portable device design
- Data storage and management
- Patient data privacy compliance
- Remote software updates
- Multilingual support
- Customizable reporting
Id
SW0612
Integration Partners
Integrations
- DermoGenius Ultra dermoscopy system
- Electronic Medical Record (EMR) systems in Germany
- Skinobs cosmetic testing platform
- Al Shirawi Healthcare solutions in UAE
Languages Supported
- English
- Swedish
- German
- French
- Italian
- Spanish
- Dutch
- Danish
- Norwegian
- Finnish
- Swiss German
- Austrian German
- Belgian Dutch
- Canadian French
- Japanese
- Korean
- Chinese
Last Updated
2025-10-11
License
commercial
Market Segment
- enterprise
- consumer
- research
- clinical
- medical device
Optional Modules
- eBarrier Score for skin barrier assessment
- Non-melanoma skin cancer (NMSC) application
Os Platforms
- Web
- iOS
- Android
- Windows
- macOS
- Linux
Pricing Details
Contact vendor for pricing information.
Pricing Model
enterprise_quote
Privacy Features
- BAA available
- consent mgmt
- anonymization
- data minimization
Product Code
SW0612
Product Name
Nevisense
Ratings
Regions Available
Related Urls
Release Year
2015
Security Features
- Encryption
- RBAC
- SSO/SAML
- audit logs
- 2FA
- DLP
Specialties
Support Channels
System Requirements
Windows 10 or later, macOS 10.15 or later, iOS 12 or later, Android 9 or later
Target Users
- clinicians
- dermatologists
- patients
- researchers
- healthcare providers
- medical professionals
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "Nevisense",
"company_name": "SciBase",
"product_url": "https://scibase.com/us/",
"company_url": "https://scibase.com",
"related_urls": [
"https://www.prnewswire.com/news-releases/scibase-reaches-milestone-with-over-300-000-patients-tested-with-nevisense-302465743.html",
"https://www.prnewswire.com/news-releases/scibase-launches-next-generation-nevisense-302426598.html",
"https://www.prnewswire.com/news-releases/scibase-announces-sale-of-nevisense-to-nih-us-302261009.html",
"https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
],
"product_code": "SW0612",
"summary": "Nevisense is a non-invasive diagnostic device developed by SciBase, utilizing advanced Electrical Impedance Spectroscopy (EIS) combined with artificial intelligence to enhance the early detection of skin cancers, particularly melanoma, at the point of care.",
"description": "Nevisense is a point-of-care diagnostic device that employs Electrical Impedance Spectroscopy (EIS) technology integrated with artificial intelligence to assess suspicious pigmented skin lesions. It provides clinicians with objective, actionable data to support early detection and management of skin cancers, including melanoma and non-melanoma types. The device is FDA-approved and CE-marked, ensuring its safety and efficacy in clinical settings. Nevisense has been utilized in over 300,000 patient tests globally, demonstrating its effectiveness in improving diagnostic accuracy and patient outcomes. The platform has evolved through several iterations, with Nevisense 3.0 offering a streamlined workflow and enhanced performance, and Nevisense V introducing an updated user interface and improved display resolution. Additionally, Nevisense has been adapted for research applications, such as assessing skin barrier function in atopic dermatitis studies. SciBase continues to advance Nevisense, aiming to expand its capabilities and applications in dermatology.",
"categories": [
"diagnostic Support",
"clinical Care",
"patient Facing",
"oncology Care",
"medical Device",
"ai Clinical Documentation Integrity",
"point-of-care",
"clinical Decision Support",
"Diagnostic",
"Clinical",
"Patient-facing",
"Dermatology",
"Oncology",
"Medical Device",
"Ai-powered",
"Non-invasive",
"Point-of-care",
"Skin Cancer Detection"
],
"market_segment": [
"enterprise",
"consumer",
"research",
"clinical",
"medical device"
],
"target_users": [
"clinicians",
"dermatologists",
"patients",
"researchers",
"healthcare providers",
"medical professionals"
],
"specialties": [
"Dermatology",
"Oncology",
"Skin Cancer",
"Melanoma",
"Non-melanoma Skin Cancer",
"Atopic Dermatitis",
"Skin Barrier Assessment"
],
"regions_available": [
"United States",
"Europe",
"Australia",
"Sweden",
"Germany",
"United Kingdom",
"France",
"Italy",
"Spain",
"Netherlands",
"Denmark",
"Norway",
"Finland",
"Switzerland",
"Austria",
"Belgium",
"Canada",
"Japan",
"South Korea",
"China"
],
"languages_supported": [
"English",
"Swedish",
"German",
"French",
"Italian",
"Spanish",
"Dutch",
"Danish",
"Norwegian",
"Finnish",
"Swiss German",
"Austrian German",
"Belgian Dutch",
"Canadian French",
"Japanese",
"Korean",
"Chinese"
],
"pricing_model": "enterprise_quote",
"pricing_details": "Contact vendor for pricing information.",
"license": "commercial",
"company_offices": [
"Sweden",
"United States",
"Germany",
"United Kingdom",
"France",
"Italy",
"Spain",
"Netherlands",
"Denmark",
"Norway"
],
"company_founding": "2000",
"deployment_model": [
"SaaS",
"on_prem",
"hybrid"
],
"os_platforms": [
"Web",
"iOS",
"Android",
"Windows",
"macOS",
"Linux"
],
"features": [
"Non-invasive melanoma detection",
"Skin barrier assessment",
"Atopic dermatitis evaluation",
"AI-driven diagnostic support",
"Electrical Impedance Spectroscopy (EIS) technology",
"Point-of-care testing",
"Clinical workflow integration",
"FDA-approved system",
"CE marked in Europe",
"TGA approval in Australia",
"MDR certified in Europe",
"Clinical studies supporting efficacy",
"User-friendly interface",
"Real-time results",
"Portable device design",
"Data storage and management",
"Patient data privacy compliance",
"Remote software updates",
"Multilingual support",
"Customizable reporting"
],
"optional_modules": [
"eBarrier Score for skin barrier assessment",
"Non-melanoma skin cancer (NMSC) application"
],
"integrations": [
"DermoGenius Ultra dermoscopy system",
"Electronic Medical Record (EMR) systems in Germany",
"Skinobs cosmetic testing platform",
"Al Shirawi Healthcare solutions in UAE"
],
"data_standards": [
"FHIR",
"HL7 v2",
"DICOM",
"SNOMED",
"ICD-10"
],
"api_available": "unknown",
"system_requirements": "Windows 10 or later, macOS 10.15 or later, iOS 12 or later, Android 9 or later",
"compliance": [
"HIPAA",
"GDPR",
"HITECH",
"SOC 2",
"ISO 27001",
"MDR",
"FDA 510(k)",
"CE/MDR",
"TGA",
"ISO 13485"
],
"certifications": [
"FDA 510(k)",
"CE/MDR",
"TGA",
"ISO 13485",
"MDR"
],
"security_features": [
"Encryption",
"RBAC",
"SSO/SAML",
"audit logs",
"2FA",
"DLP"
],
"privacy_features": [
"BAA available",
"consent mgmt",
"anonymization",
"data minimization"
],
"data_residency": "EU-only, US/EU regions, BYO cloud region",
"customers": [
"Over 300,000 patients tested with Nevisense"
],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "2015",
"integration_partners": [],
"id": "SW0612",
"slug": "nevisense",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/nevisense.json"
}
}